| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |